Coronary artery disease trials in China

In China 290 Also abroad 1313

290 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
The Application of T1 Mapping in Real-World
Where
Beijing
People
2,000
Run by
Chinese Academy of Medical Sciences, Fuwai Hospital
See details and how to joinNCT07354646
Phase 4Not yet taking people in China
Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery
Where
Beijing
Age
45 years and over
People
80
Run by
Peking University First Hospital
See details and how to joinNCT07912801
Phase 2Taking people
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Where
Beijing, Changchun, Changsha, Chengdu, Daqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Lanzhou, Shanghai, Shenyang, Suzhou, Tianjin, Wenzhou, Wuhan, Xi'an
Age
18 years to 80 years
People
456 worldwide
Run by
Beijing Inno Medicine Co., Ltd.
See details and how to joinNCT07521007
No phaseNot yet taking people in China
Partial Cardiac Denervation for Preventing Atrial Fibrillation After CABG
Where
Beijing, Changsha, Guangzhou, Nanjing, Zhenzhou
Age
18 years and over
People
1,470
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT07918781
No phaseNot yet taking people in China
Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT)
Where
Hangzhou
Age
18 years and over
People
106
Run by
Sir Run Run Shaw Hospital
See details and how to joinNCT07920055
No phaseNot yet taking people in China
Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD)
Where
Hangzhou
Age
18 years and over
People
1,768
Run by
Sir Run Run Shaw Hospital
See details and how to joinNCT07920133
No phaseNot yet taking people in China
Out-Patient Proactive Observation With Wearable-Assisted Tracking for Cardiovascular Health Management
Where
Beijing
Age
18 years and over
People
400
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT07912671
Phase 4Taking people
Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction
Where
Changzhou, Chongqing, Dalian, Daqing, Dongguan, Fengcheng, Guangzhou, Hainan, Hangzhou, Hefei, Huai'an, Lianyungang, Liyang, Nanchang, Nanjing, Nanning, Nantong, Neimeng, Qingdao, Shandong, Shanghai, Shenyang, Shenzhen, Suining, Suqian, Suzhou, Taihe, Taishan, Taizhou, Wenzhou, Wuxi, Xuzhou, Yancheng, Yangzhou, Zhengzhou, Zhenjiang
Age
18 years to 75 years
People
2,260
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT05410925
Phase 4Taking people
CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes Patients With Stage 4 CKM Syndrome
Where
Shenyang
Age
18 years and over
People
110
Run by
Shenyang Northern Hospital
See details and how to joinNCT07351643
Phase 3Not yet taking people in China
Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients
Where
Dalian, Fuzhou, Guangdong, Guangzhou, Hangzhou, Hefei, Jinan, Jining, Luoyang, Nanjing, Qingdao, Quzhou, Shanghai, Taiyuan, Xi’an, Zhengzhou
Age
18 years to 75 years
People
1,188
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07725484
Phase 4Taking people
Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
Where
Beijing, Tangshan
Age
18 years to 75 years
People
3,684
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT06096909
No phaseTaking people
Treatment of Primary Coronary Artery Vascular Lesions With Biolimus Coated Coronary Balloon Dilation Catheter
Where
Lanzhou, Nanning
Age
18 years and over
People
400
Run by
JW Medical Systems Ltd
See details and how to joinNCT06385067
No phaseTaking people
CCTA-Based vs CAG-Based CABG: A Multicenter Pragmatic Non-Inferiority Trial
Where
Shanghai
Age
18 years and over
People
826
Run by
Ruijin Hospital
See details and how to joinNCT07769008
Phase 3Taking people
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Where
Beijing, Bozhou, Changsha, Chengdu, Chifeng, Daqing, Dongguan, Fuzhou, Guangzhou, Hangzhou, Harbin, Hebi, Hefei, Hengyang, Heze, Huangshi, Jinan, Jining, Jinzhou, Kaifeng, Kunming, Lanzhou, Lishui, Liuzhou, Luoyang, Luzhou, Mianyang, Nanjing, Nanning, Panjin, Pingxiang, Puyang, Qingyang, Shanghai, Shenyang, Shijiazhuang, Shiyan, Suzhou, Taiyuan, Tangshan, Tianjin, Wuhan, Xi'an, Xi’an, Xianyang, Xingtai, Xinxiang, Yichang, Yulin, Yuncheng, Zhangjiakou
Age
18 years to 80 years
People
636
Run by
Tasly Pharmaceutical Group Co., Ltd
See details and how to joinNCT07687186
Phase 4Taking people
Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease
Where
Shanghai
Age
1 month to 18 years
People
10
Run by
Children's Hospital of Fudan University
See details and how to joinNCT06978439
Phase 4Not yet taking people in China
Coronary MicrovAscular Diseases Intervention With Compound Danshen Dropping Pills
Where
Jinan
Age
18 years to 80 years
People
496
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07885462
No phaseNot yet taking people in China
AI-Based CT Analysis of Coronary Plaque Evolution
Where
Hangzhou, Yuhuan, Zhoushan
Age
18 years and over
People
326
Run by
Zhejiang Hospital
See details and how to joinNCT07886996
No phaseTaking people
Product Surveillance Registry
Where
Beijing, Chengdu, Dalian, Guangzhou, Hangzhou, Harbin, Hefei, Kunming, Nanchang, Nanjing, Nanning, Shanghai, Suzhou, Ürümqi
People
100,000 worldwide
Run by
Medtronic
See details and how to joinNCT01524276
No phaseTaking people
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Where
Beijin, Beijing, Guangzhou, Wuhan, Xi’an
Age
18 years and over
People
1,616 worldwide
Run by
Boston Scientific Corporation
See details and how to joinNCT06959524
No phaseTaking people
Prospective Study Protocol for Multiparametric PCCT Assessment of Early Ventricular Outcomes After CABG
Where
Beijing
Age
18 years to 100 years
People
150
Run by
Xin Lou
See details and how to joinNCT07883499
No phaseTaking people
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Where
Jilin City, Shanghai
Age
18 years and over
People
754 worldwide
Run by
Sunnybrook Health Sciences Centre
See details and how to joinNCT05427370
Phase 4Taking people
Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques
Where
Beijing
Age
18 years to 80 years
People
2,190
Run by
Beijing Anzhen Hospital
See details and how to joinNCT06855537
No phaseTaking people
Observational Study for Left Main Disease Treatment
Where
Shanghai
Age
18 years and over
People
10,000 worldwide
Run by
Seung-Jung Park
See details and how to joinNCT01341327
No phaseNot yet taking people in China
IVUS-Guided Sirolimus-Coated Balloon Versus Sirolimus-Eluting Stent for De Novo Large Vessel Lesions in ACS
Where
Beijing
Age
18 years and over
People
150
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT07796412
Phase 4Not yet taking people in China
IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI
Where
Xuzhou
Age
18 years to 75 years
People
3,300
Run by
The Affiliated Hospital of Xuzhou Medical University
See details and how to joinNCT07875179